Physician profile
John Powell
NPI 1437152451
$2,408.52
in general payments reported to CMS, 2019-2025
18 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $536 · 2020: $257 · 2021: $1,067 · 2022: $252 · 2023: $47.05 · 2024: $249.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $296.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $296.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $1,174.01 | 2020-2024 | |
| Elite Orthopedics, LLC | $298.90 | 2021-2024 | |
| Smith+Nephew, INC. | $190.72 | 2019-2023 | Pico 14, Pico 7 |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $125.00 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $116.72 | 2024 | Airsupra |
| Zimmer Biomet Holdings, INC. | $109.15 | 2022-2023 | Persona |
| Depuy Synthes Sales INC. | $99.36 | 2019-2020 | |
| Horizon Therapeutics Plc | $55.88 | 2019 | |
| Endo Pharmaceuticals INC. | $54.16 | 2019-2022 | |
| Pacira Therapeutics, INC. | $34.86 | 2019-2021 | |
| Electronic Waveform Lab, INC. | $32.07 | 2019 | |
| Ironshore Pharmaceuticals INC. | $23.79 | 2024 | |
| Ethicon US, LLC | $21.11 | 2019 | |
| Ferring Pharmaceuticals INC. | $17.67 | 2019 | |
| Celularity INC. | $16.00 | 2019 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baudax Bio INC. | $13.98 | 2021 | |
| Abbvie INC. | $13.59 | 2021 | |
| Wright Medical Technology, INC. | $11.55 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.